Oral Arsenic With ATRA for Newly Diagnosed Patients With Acute Promyelocytic Leukemia
Oral Arsenic With ATRA for Newly Diagnosed Patients With Acute Promyelocytic Leukemia
Recruiting · NCT06982274 · Registry updated 2025-05-30Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Oral Arsenic With ATRA for Newly Diagnosed Patients With Acute Promyelocytic Leukemia | Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, acute myeloid leukemia, acute promyelocytic leukemia, hematologic disorder, leukemia, myeloid leukemia, neoplasm | Recruiting | Phase 2 | 2025-05-30 | NCT06982274 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| American Society of Hematology | 7 |
| Instituto do Cancer do Estado de São Paulo | 26 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Instituto do Cancer do Estado de Sao Paulo | São Paulo | Brazil | 3 |